X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.indianpharmapost.com/news/janssen-tremfya-excels-as-psoriasis-treatment-outshining-il-17s-says-globaldata-14200
https://www.prnewswire.com/news-releases/janssen-submits-new-drug-application-to-us-fda-seeking-approval-of-investigational-single-tablet-combination-therapy-of-macitentan-and-tadalafil-for-treatment-of-patients-with-pulmonary-arterial-hypertension-pah-301834852.html
https://www.globenewswire.com/news-release/2023/05/25/2675919/0/en/Janssen-Seeks-European-Commission-Approval-of-a-New-Indication-for-CARVYKTI-ciltacabtagene-autoleucel-cilta-cel-for-the-Earlier-Treatment-of-Patients-with-Relapsed-and-Refractory-M.html
https://johnsonandjohnson.gcs-web.com/static-files/4120e707-3112-4f0b-a1d2-7015893e855c
https://endpts.com/janssen-reports-decline-in-2022-net-prices-as-out-of-pocket-costs-grow/
https://johnsonandjohnson.gcs-web.com/static-files/a6b05ebe-8b48-40ad-8d48-cb8cf68c3c96
https://www.prnewswire.com/news-releases/protagonist-reports-positive-results-from-phase-1-and-pre-clinical-studies-of-oral-interleukin-23-receptor-antagonist-jnj-2113-301823039.html
https://www.clinicaltrialsarena.com/news/janssen-tremyfa-ulcerative-colitis/
https://www.prnewswire.com/news-releases/first-phase-3-tremfya-guselkumab-data-in-inflammatory-bowel-disease-show-positive-induction-results-among-patients-with-moderately-to-severely-active-ulcerative-colitis-301818808.html
https://www.fiercebiotech.com/biotech/jj-refuels-car-t-ambitions-245m-upfront-cellular-biomedicine-pair-therapies
Market Place
Share 
